Recombinant Human Pro-Urokinase vs. Alteplase Within 4.5 hours of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By afschroeder • July 8, 2025

Hashmi TM, Shafiq A, Zia R, Ashraf H, Burhan M, Ahmed M, Mesmar A, Ahmed R, Fonarow GC. Recombinant Human Pro-Urokinase vs. Alteplase Within 4.5 hours of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2025 Jul 5:108392. doi: 10.1016/j.jstrokecerebrovasdis.2025.108392. Epub ahead of print. PMID: 40623511.

Tags: alteplase, Cardiology/Epi, Publications, recombinant human pro-urokinase, stroke, thrombolytic therapy

Development of a Primary Care Cardio-Kidney Risk Navigator for Clinical Decision Support

Gluckman TJ, Birkeland K, Bhatt A, Budoff MJ, Danna SC, Desai NR, Norfolk E, Elbedewe A, Kiernan G, Pachpor R, Hirsch J. Development of a[...]

Hidden risk in normal myocardial perfusion scans: AI-detected proximal coronary calcium on CT attenuation maps improves prognosis

Zhou J, Miller RJH, Shanbhag A, Killekar A, Han D, Patel KK, Pieszko K, Yi J, Urs MK, Ramirez G, Lemley M, Kavanagh PB, Liang[...]

Innervation of the Human Atrioventricular Node via the Inferior Pyramidal Space: Characterization Using Intersectional Strategies

Sato T, Mori S, Hanna P, Hadaya JE, Miyazaki Y, Kirkland LG, Hoover DB, Ajijola OA, Shivkumar K. Innervation of the Human Atrioventricular Node via[...]